Stem cell therapy in necrotizing enterocolitis: Current state and future directions

If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2018-02
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Abstract

Stem cell therapy is a promising treatment modality for necrotizing enterocolitis. Among the many promising stem cells identified to date, it is likely that mesenchymal stem cells will be the most useful and practical cell-based therapies for this condition. Using acellular components such as exosomes or other paracrine mediators are promising as well. Multiple mechanisms are likely at play in the positive effects provided by these cells, and further research is underway to further elucidate these effects.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Drucker, N. A., McCulloh, C. J., Li, B., Pierro, A., Besner, G. E., & Markel, T. A. (2018). Stem cell therapy in necrotizing enterocolitis: Current state and future directions. Seminars in pediatric surgery, 27(1), 57–64. doi:10.1053/j.sempedsurg.2017.11.011
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Seminars in Pediatric Surgery
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}